CA3151164C - Compositions comprenant des extraits naturels pour stimuler la reponse immunitaire - Google Patents

Compositions comprenant des extraits naturels pour stimuler la reponse immunitaire Download PDF

Info

Publication number
CA3151164C
CA3151164C CA3151164A CA3151164A CA3151164C CA 3151164 C CA3151164 C CA 3151164C CA 3151164 A CA3151164 A CA 3151164A CA 3151164 A CA3151164 A CA 3151164A CA 3151164 C CA3151164 C CA 3151164C
Authority
CA
Canada
Prior art keywords
composition
infection
dosage form
subject
propolis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3151164A
Other languages
English (en)
Other versions
CA3151164A1 (fr
Inventor
Abdulhameed Abdulridha K. Al-Shaibani
Abderrahim Maallah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiban Canada Inc
Original Assignee
Shiban Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiban Canada Inc filed Critical Shiban Canada Inc
Priority claimed from PCT/CA2021/051604 external-priority patent/WO2022099414A1/fr
Publication of CA3151164A1 publication Critical patent/CA3151164A1/fr
Application granted granted Critical
Publication of CA3151164C publication Critical patent/CA3151164C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
CA3151164A 2020-11-13 2021-11-11 Compositions comprenant des extraits naturels pour stimuler la reponse immunitaire Active CA3151164C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063113319P 2020-11-13 2020-11-13
US63/113,319 2020-11-13
PCT/CA2021/051604 WO2022099414A1 (fr) 2020-11-13 2021-11-11 Compositions comprenant des extraits naturels pour stimuler la réponse immunitaire

Publications (2)

Publication Number Publication Date
CA3151164A1 CA3151164A1 (fr) 2022-05-13
CA3151164C true CA3151164C (fr) 2023-01-03

Family

ID=81535331

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3151164A Active CA3151164C (fr) 2020-11-13 2021-11-11 Compositions comprenant des extraits naturels pour stimuler la reponse immunitaire

Country Status (3)

Country Link
US (1) US20230057065A1 (fr)
EP (1) EP4175653A4 (fr)
CA (1) CA3151164C (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922351A (en) * 1991-03-27 1999-07-13 Bayer Corporation Lubricants for use in tabletting
CN104920772A (zh) * 2015-05-27 2015-09-23 闭炳春 一种防蛀牙口香糖及其制备方法
CN105687226B (zh) * 2016-01-27 2018-04-13 中国人民解放军疾病预防控制所 一种用于抑制冠状病毒感染的制剂
US20190008905A1 (en) * 2017-07-07 2019-01-10 Noori AL-WAILI Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases
CN110888443A (zh) * 2019-12-04 2020-03-17 上海大学 一种移动机器人旋转避障方法及系统

Also Published As

Publication number Publication date
EP4175653A1 (fr) 2023-05-10
US20230057065A1 (en) 2023-02-23
EP4175653A4 (fr) 2024-05-15
CA3151164A1 (fr) 2022-05-13

Similar Documents

Publication Publication Date Title
Cubeddu et al. Antiemetic activity of ondansetron in acute gastroenteritis
Patrício et al. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis
CN105482129B (zh) 抗癌萃取物及化合物
US9968582B2 (en) Use of a benzoate containing composition in urea cycle disorders and neurodegenerative disorders
JP2022545341A (ja) アフリカ豚熱を治療するための薬物組成物及びその使用
Xiong et al. Piceatannol-3′-O-β-D-glucopyranoside attenuates colistin-induced neurotoxicity by suppressing oxidative stress via the NRF2/HO-1 pathway
BRPI0513321B1 (pt) Vírus parapox em combinação com outros agentes antivirais para o tratamento de doenças virais
CA3151164C (fr) Compositions comprenant des extraits naturels pour stimuler la reponse immunitaire
US20080166426A1 (en) Anitbacterial compositions and methods of treatment
Osirim et al. Chemotherapeutic interaction of Vernonia amygdalina (Delile) leaf extract with Artesunate and Amodiaquine in murine malaria model
WO2016057840A1 (fr) Compositions de cannabidiol incluant des mélanges et leurs utilisations
WO2022099414A1 (fr) Compositions comprenant des extraits naturels pour stimuler la réponse immunitaire
KR20130096088A (ko) 백지 추출물을 유효성분으로 함유하는 장출혈성 대장균 감염증의 예방 또는 치료용 약학 조성물
CN102711750A (zh) 多环化合物作为抗aids剂的制药用途
AU2022261987A1 (en) Compositions and methods for treatment of conditions using fractionated honey
See et al. Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954
US20090076132A1 (en) Antiviral compositions and methods of treatment
AU760967B2 (en) Herbal composition for the prophylaxis and treatment of AIDS
WO2003002126A1 (fr) Agent antiretroviral en combinaison avec du polyphenol de the pour le traitement d'infections virales
Alamri Effects of Myrrh on HSV-1 Using Plaque Assay
US20160243182A1 (en) Use of cissampelos pareira extracts for treating dengue
JP6942350B2 (ja) 抗ウイルス剤及び抗ウイルス用組成物
GB2622661A (en) Composition
CN117323362A (zh) 一种抗幽门螺杆菌的植物挥发油组合物
CA3222700A1 (fr) Procede et composition pour la prevention et le traitement d'infections virales